Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Dysregulation of miR-200 family microRNAs and epithelial-mesenchymal transition markers in oral squamous cell carcinoma.

Arunkumar G, Deva Magendhra Rao AK, Manikandan M, Prasanna Srinivasa Rao H, Subbiah S, Ilangovan R, Murugan AK, Munirajan AK.

Oncol Lett. 2018 Jan;15(1):649-657. doi: 10.3892/ol.2017.7296. Epub 2017 Oct 31.

2.

Long noncoding RNAs: emerging players in thyroid cancer pathogenesis.

Murugan AK, Munirajan AK, Alzahrani AS.

Endocr Relat Cancer. 2018 Feb;25(2):R59-R82. doi: 10.1530/ERC-17-0188. Epub 2017 Nov 16. Review.

3.

A high rate of novel CYP11B1 mutations in Saudi Arabia.

Alzahrani AS, Alswailem MM, Murugan AK, Alhomaidah DS, Capper CP, Auchus RJ, Qasem E, Alzahrani OS, Al-Sagheir A, Bin-Abbas B.

J Steroid Biochem Mol Biol. 2017 Nov;174:217-224. doi: 10.1016/j.jsbmb.2017.09.018. Epub 2017 Sep 28.

PMID:
28962970
4.

Mutational analysis of rare subtypes of congenital adrenal hyperplasia in a highly inbred population.

Alswailem MM, Alzahrani OS, Alhomaidah DS, Alasmari R, Qasem E, Murugan AK, Alsagheir A, Brema I, Abbas BB, Almehthel M, Almeqbali A, Alzahrani AS.

Mol Cell Endocrinol. 2018 Feb 5;461:105-111. doi: 10.1016/j.mce.2017.08.022. Epub 2017 Sep 6.

PMID:
28870780
5.

Genotyping of CYP2C9 and VKORC1 polymorphisms predicts south Indian patients with deep vein thrombosis as fast metabolizers of warfarin/acenocoumarin.

Arunkumar G, Vishnuprabu D, Nupur B, Vidyasagaran T, Murugan AK, Munirajan AK.

Drug Discov Ther. 2017;11(4):198-205. doi: 10.5582/ddt.2017.01031.

6.

Self-folding origami at any energy scale.

Pinson MB, Stern M, Carruthers Ferrero A, Witten TA, Chen E, Murugan A.

Nat Commun. 2017 May 18;8:15477. doi: 10.1038/ncomms15477.

7.

Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer.

Noman AS, Uddin M, Chowdhury AA, Nayeem MJ, Raihan Z, Rashid MI, Azad AK, Rahman ML, Barua D, Sultana A, Shirin A, Ferdous J, Parag RR, Rahman SM, Mahmud MR, Jerin CS, Jahan N, Siddiqua A, Ara T, Sabur EB, Alam SS, Baidya S, Akther S, Rahman MZ, Banu T, Murugan AK, Sabri S, Islam SMS, Karakas B, Aboussekhra A, Yeger H, Farhat WA, Islam SS.

Sci Rep. 2017 May 11;7(1):1796. doi: 10.1038/s41598-017-01268-4.

8.

Endovascular pulmonary artery inflatable balloon-induced hypotension: A novel technique for clipping giant intracranial aneurysms.

Kumar VRR, Subramaniam SB, Murugan ABG, Bapu KRS.

Neurol India. 2017 May-Jun;65(3):566-569. doi: 10.4103/neuroindia.NI_301_16.

9.

Long non-coding RNA CCAT1 is overexpressed in oral squamous cell carcinomas and predicts poor prognosis.

Arunkumar G, Murugan AK, Prasanna Srinivasa Rao H, Subbiah S, Rajaraman R, Munirajan AK.

Biomed Rep. 2017 Apr;6(4):455-462. doi: 10.3892/br.2017.876. Epub 2017 Mar 17.

10.

Absence of the frequently reported PIK3CA, CASP8, and NOTCH1 mutations in South Indian oral cancers.

Arunkumar G, Murugan AK, Nagarajan M, Ajay C, Rajaraman R, Munirajan AK.

Oral Dis. 2017 Jul;23(5):669-673. doi: 10.1111/odi.12655. Epub 2017 Mar 24.

PMID:
28181739
11.

Topologically protected modes in non-equilibrium stochastic systems.

Murugan A, Vaikuntanathan S.

Nat Commun. 2017 Jan 10;8:13881. doi: 10.1038/ncomms13881.

12.

Single Point Mutations in Pediatric Differentiated Thyroid Cancer.

Alzahrani AS, Murugan AK, Qasem E, Alswailem M, Al-Hindi H, Shi Y.

Thyroid. 2017 Feb;27(2):189-196. doi: 10.1089/thy.2016.0339. Epub 2016 Dec 20.

PMID:
27824297
13.

Incidence and patterns of maxillofacial trauma-a retrospective analysis of 3611 patients-an update.

Manodh P, Prabhu Shankar D, Pradeep D, Santhosh R, Murugan A.

Oral Maxillofac Surg. 2016 Dec;20(4):377-383. Epub 2016 Sep 23.

PMID:
27663240
14.

Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer.

Murugan AK, Qasem E, Al-Hindi H, Shi Y, Alzahrani AS.

J Transl Med. 2016 Jul 7;14(1):204. doi: 10.1186/s12967-016-0958-x.

15.

Corrigendum: Sustainable, Rapid Synthesis of Bright-Luminescent CuInS2-ZnS Alloyed Nanocrystals: Multistage Nano-xenotoxicity Assessment and Intravital Fluorescence Bioimaging in Zebrafish-Embryos.

Chetty SS, Praneetha S, Basu S, Sachidanandan C, Murugan AV.

Sci Rep. 2016 Jun 27;6:28607. doi: 10.1038/srep28607. No abstract available.

16.
17.

Information capacity of specific interactions.

Huntley MH, Murugan A, Brenner MP.

Proc Natl Acad Sci U S A. 2016 May 24;113(21):5841-6. doi: 10.1073/pnas.1520969113. Epub 2016 May 6.

18.

Receptor arrays optimized for natural odor statistics.

Zwicker D, Murugan A, Brenner MP.

Proc Natl Acad Sci U S A. 2016 May 17;113(20):5570-5. doi: 10.1073/pnas.1600357113. Epub 2016 Apr 21.

19.

Kirsten Ras* oncogene: significance of its discovery in human cancer research.

Tsuchida N, Murugan AK, Grieco M.

Oncotarget. 2016 Jul 19;7(29):46717-46733. doi: 10.18632/oncotarget.8773. Review.

20.

C(sp(2))-H Functionalization of 2H-Indazoles at C3-Position via Palladium(II)-Catalyzed Isocyanide Insertion Strategy Leading to Diverse Heterocycles.

Vidyacharan S, Murugan A, Sharada DS.

J Org Chem. 2016 Apr 1;81(7):2837-48. doi: 10.1021/acs.joc.6b00048. Epub 2016 Mar 18.

PMID:
26954483
21.

HABP2 Gene Mutations Do Not Cause Familial or Sporadic Non-Medullary Thyroid Cancer in a Highly Inbred Middle Eastern Population.

Alzahrani AS, Murugan AK, Qasem E, Al-Hindi H.

Thyroid. 2016 May;26(5):667-71. doi: 10.1089/thy.2015.0537. Epub 2016 Apr 8.

PMID:
26906432
22.

TERT Promoter Mutations in Thyroid Cancer.

Alzahrani AS, Alsaadi R, Murugan AK, Sadiq BB.

Horm Cancer. 2016 Jun;7(3):165-77. doi: 10.1007/s12672-016-0256-3. Epub 2016 Feb 22. Review.

PMID:
26902827
23.

Erratum to: TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas.

Vinothkumar V, Arunkumar G, Revathidevi S, Arun K, Manikandan M, Rao AK, Rajkumar KS, Ajay C, Rajaraman R, Ramani R, Murugan AK, Munirajan AK.

Tumour Biol. 2016 May;37(5):7005. No abstract available.

PMID:
26897749
24.

Uncommon TERT Promoter Mutations in Pediatric Thyroid Cancer.

Alzahrani AS, Qasem E, Murugan AK, Al-Hindi HN, AlKhafaji D, Almohanna M, Xing M, Alhomaidah D, AlSwailem M.

Thyroid. 2016 Feb;26(2):235-41. doi: 10.1089/thy.2015.0510. Epub 2016 Jan 21.

PMID:
26711586
25.

TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas.

Vinothkumar V, Arunkumar G, Revathidevi S, Arun K, Manikandan M, Rao AK, Rajkumar KS, Ajay C, Rajaraman R, Ramani R, Murugan AK, Munirajan AK.

Tumour Biol. 2016 Jun;37(6):7907-13. doi: 10.1007/s13277-015-4694-2. Epub 2015 Dec 23. Erratum in: Tumour Biol. 2016 May;37(5):7005.

PMID:
26700669
26.

MicroRNAs: Modulators of the Ras Oncogenes in Oral Cancer.

Murugan AK, Munirajan AK, Alzahrani AS.

J Cell Physiol. 2016 Jul;231(7):1424-31. doi: 10.1002/jcp.25269. Epub 2015 Dec 28. Review.

PMID:
26620726
27.

Absence of somatic mutations of the mTOR gene in differentiated thyroid cancer.

Murugan AK, Humudh EA, Qasem E, Al-Hindi H, Almohanna M, Hassan ZK, Alzahrani AS.

Meta Gene. 2015 Sep 27;6:69-71. doi: 10.1016/j.mgene.2015.08.005. eCollection 2015 Dec.

28.

Proposed Guidelines for Treatment of Concomitant Distal Radius and Distal Ulna Fractures.

Liang B, Lai JM, Murugan A, Chee KG, Sechachalam S, Foo TL.

Hand Surg. 2015 Oct;20(3):396-401. doi: 10.1142/S0218810415500306.

PMID:
26388000
29.

TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.

Qasem E, Murugan AK, Al-Hindi H, Xing M, Almohanna M, Alswailem M, Alzahrani AS.

Endocr Relat Cancer. 2015 Dec;22(6):901-8. doi: 10.1530/ERC-15-0396. Epub 2015 Sep 9.

30.

Spinal cord surgery in left lateral position with tilt in a pregnant patient with intradural extramedullary Schwannoma.

Babu S, Murugan A, Thamarai.

Indian J Anaesth. 2015 Jul;59(7):453-5. doi: 10.4103/0019-5049.160967. No abstract available.

31.

Undesired usage and the robust self-assembly of heterogeneous structures.

Murugan A, Zou J, Brenner MP.

Nat Commun. 2015 Feb 11;6:6203. doi: 10.1038/ncomms7203.

PMID:
25669898
32.

New insights into seaweed polyphenols on glucose homeostasis.

Murugan AC, Karim MR, Yusoff MB, Tan SH, Asras MF, Rashid SS.

Pharm Biol. 2015 Aug;53(8):1087-97. doi: 10.3109/13880209.2014.959615. Epub 2015 Jan 29. Review.

PMID:
25630358
33.

Multifarious assembly mixtures: systems allowing retrieval of diverse stored structures.

Murugan A, Zeravcic Z, Brenner MP, Leibler S.

Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):54-9. doi: 10.1073/pnas.1413941112. Epub 2014 Dec 22.

34.

A novel method for measuring trace amounts of total sulphur-containing compounds in hydrogen.

Downey ML, Murugan A, Bartlett S, Brown AS.

J Chromatogr A. 2015 Jan 2;1375:140-5. doi: 10.1016/j.chroma.2014.11.076. Epub 2014 Dec 4.

PMID:
25526978
35.

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.

Xing M, Liu R, Liu X, Murugan AK, Zhu G, Zeiger MA, Pai S, Bishop J.

J Clin Oncol. 2014 Sep 1;32(25):2718-26. doi: 10.1200/JCO.2014.55.5094. Epub 2014 Jul 14.

36.

Quantifying selection in immune receptor repertoires.

Elhanati Y, Murugan A, Callan CG Jr, Mora T, Walczak AM.

Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9875-80. doi: 10.1073/pnas.1409572111. Epub 2014 Jun 18.

37.

Cross-finger dermal pocketing to augment venous outflow for distal fingertip replantation.

Tan VH Jr, Murugan A, Foo TL, Puhaindran ME.

Tech Hand Up Extrem Surg. 2014 Sep;18(3):131-4. doi: 10.1097/BTH.0000000000000051.

PMID:
24854151
38.
39.

TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.

Liu X, Qu S, Liu R, Sheng C, Shi X, Zhu G, Murugan AK, Guan H, Yu H, Wang Y, Sun H, Shan Z, Teng W, Xing M.

J Clin Endocrinol Metab. 2014 Jun;99(6):E1130-6. doi: 10.1210/jc.2013-4048. Epub 2014 Mar 11.

40.

Preparation and validation of fully synthetic standard gas mixtures with atmospheric isotopic composition for global CO2 and CH4 monitoring.

Brewer PJ, Brown RJ, Miller MN, MiƱarro MD, Murugan A, Milton MJ, Rhoderick GC.

Anal Chem. 2014 Feb 4;86(3):1887-93. doi: 10.1021/ac403982m. Epub 2014 Jan 24.

PMID:
24410374
41.

Histone deacetylation of NIS promoter underlies BRAF V600E-promoted NIS silencing in thyroid cancer.

Zhang Z, Liu D, Murugan AK, Liu Z, Xing M.

Endocr Relat Cancer. 2014 Jan 30;21(2):161-73. doi: 10.1530/ERC-13-0399. Print 2014 Apr.

42.

Mutational analysis of the GNA11, MMP27, FGD1, TRRAP and GRM3 genes in thyroid cancer.

Murugan AK, Yang C, Xing M.

Oncol Lett. 2013 Aug;6(2):437-441. Epub 2013 Jun 11.

43.

Identification of RASAL1 as a major tumor suppressor gene in thyroid cancer.

Liu D, Yang C, Bojdani E, Murugan AK, Xing M.

J Natl Cancer Inst. 2013 Nov 6;105(21):1617-27. doi: 10.1093/jnci/djt249. Epub 2013 Oct 17.

44.

Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.

Rajan M, Raj V, Al-Arfaj AA, Murugan AM.

Int J Pharm. 2013 Sep 10;453(2):514-22. doi: 10.1016/j.ijpharm.2013.06.030. Epub 2013 Jun 21.

PMID:
23796828
45.

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.

Liu X, Bishop J, Shan Y, Pai S, Liu D, Murugan AK, Sun H, El-Naggar AK, Xing M.

Endocr Relat Cancer. 2013 Jul 12;20(4):603-10. doi: 10.1530/ERC-13-0210. Print 2013 Aug.

46.

Genetic deregulation of the PIK3CA oncogene in oral cancer.

Murugan AK, Munirajan AK, Tsuchida N.

Cancer Lett. 2013 Sep 28;338(2):193-203. doi: 10.1016/j.canlet.2013.04.005. Epub 2013 Apr 15. Review.

PMID:
23597702
47.

Status and effect of pesticide residues in soils under different land uses of Andaman Islands, India.

Murugan AV, Swarnam TP, Gnanasambandan S.

Environ Monit Assess. 2013 Oct;185(10):8135-45. doi: 10.1007/s10661-013-3162-y. Epub 2013 Apr 4.

PMID:
23553417
48.

Breeding and rearing of the two striped cardinalfish, Apogon quadrifasciatus (Cuvier, 1828) in captive condition.

Saravanan R, Vijayanand P, Vagelli AA, Murugan A, Shanker S, Rajagopal S, Balasubramanian T.

Anim Reprod Sci. 2013 Mar;137(3-4):237-44. doi: 10.1016/j.anireprosci.2013.01.017. Epub 2013 Feb 9.

PMID:
23434056
49.

Mutations in critical domains confer the human mTOR gene strong tumorigenicity.

Murugan AK, Alzahrani A, Xing M.

J Biol Chem. 2013 Mar 1;288(9):6511-21. doi: 10.1074/jbc.M112.399485. Epub 2013 Jan 15.

50.

Single nucleotide polymorphism rs17849071 G/T in the PIK3CA gene is inversely associated with follicular thyroid cancer and PIK3CA amplification.

Xing JC, Tufano RP, Murugan AK, Liu D, Wand G, Ladenson PW, Xing M, Trink B.

PLoS One. 2012;7(11):e49192. doi: 10.1371/journal.pone.0049192. Epub 2012 Nov 21.

Supplemental Content

Loading ...
Support Center